Hamilton Thorne Ltd. Toronto S.E.

Equities

HTL

CA4078911001

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. Other stock markets 01:29:20 16/07/2024 am IST			5-day change	1st Jan Change
1.43 ^CAD	+1.42%		-0.69%	+7.52%

23/06	Hamilton Thorne Maintained at Buy at Stifel GMP on No Impact From U.S. IVF Actions; Price Target Kept at C$2.55	MT
14/05	Hamilton Thorne Q1 Loss Widens Even as Sales Increase	MT

Hamilton Thorne Ltd. Announces Passing of Diarmaid Douglas-Hamilton, Cofounder and Chief Technology Officer

January 25, 2023 at 12:28 am IST

Hamilton Thorne Ltd. announced the passing of Diarmaid Douglas-Hamilton, Cofounder and Chief Technology Officer of Hamilton Thorne. Diarmaid passed away on January 19, 2023 at age 82, at his lab in Beverly, MA, after a heart attack.

Latest news about Hamilton Thorne Ltd.

Hamilton Thorne Maintained at Buy at Stifel GMP on No Impact From U.S. IVF Actions; Price Target Kept at C$2.55	23/06	MT
Hamilton Thorne Q1 Loss Widens Even as Sales Increase	14/05	MT
Transcript : Hamilton Thorne Ltd., Q1 2024 Earnings Call, May 14, 2024	14/05
Hamilton Thorne Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
Hamilton Thorne's Q4 Profit Falls, Sales Rise; Provides 2024 Outlook	27/03	MT
Hamilton Thorne Brief: 2024 guidance is for a sales range between US$78 and $82 million representing 10-15% organic growth; Q1 guidance is for a sales range of $19.0 to $19.4 million	27/03	MT
Hamilton Thorne Brief: Revenue of US$18.4 million for the 4th quarter; And Adj. EBITDA of $3.7 million for the quarter	27/03	MT
Transcript : Hamilton Thorne Ltd., Q4 2023 Earnings Call, Mar 27, 2024	27/03
Hamilton Thorne Ltd. Provides Earnings Guidance for the First Quarter 2024 and Full Twelve Months of 2024	27/03	CI
Hamilton Thorne Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03	CI
North American Morning Briefing : Stocks Edge -2-	27/03	DJ
Hamilton Thorne Maintained at Buy at Stifel GMP Ahead of Q4 Results; Price Target Kept at C$2.75	26/03	MT
Hamilton Thorne Ltd. Announces Executive Changes, Effective January 15, 2024	21/12	CI
Hamilton Thorne Ltd. Announces CEO Changes, Effective January 15, 2024	21/12	CI
Hamilton Thorne Q3 Sales increased 16% YoY to US$15.7 Million	13/11	MT
Hamilton Thorne Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11	CI
Transcript : Hamilton Thorne Ltd., Q3 2023 Earnings Call, Nov 13, 2023	13/11
Hamilton Thorne Brief: Q3 Sales increased 16% year over year to US$15.7 Million; Net loss was $785,000; After quarter end, Company Completed Aacquisition of Gynetics	13/11	MT
North American Morning Briefing : Stock Futures Dip as Inflation Data Looms	13/11	DJ
Hamilton Thorne Ltd. acquired Gynetics Medical Products N.V. in October, 2023.	31/23/31	CI
Hamilton Thorne Ltd. agreed to acquire Gynetics Medical Products N.V. for an enterprise value of ?18.3 million.	10/23/10	CI

Chart Hamilton Thorne Ltd.

Duration

Period

More charts

Company Profile

Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.

Sector

Advanced Medical Equipment & Technology

Calendar

21/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Hamilton Thorne Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.047 USD

Average target price

1.642 USD

Spread / Average Target

+56.89%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
HAMILTON THORNE LTD.	+7.52%	16Cr
THERMO FISHER SCIENTIFIC	+2.62%	21TCr
DANAHER CORPORATION	+6.44%	18TCr
INTUITIVE SURGICAL, INC.	+29.61%	16TCr
BOSTON SCIENTIFIC CORPORATION	+34.96%	11TCr
SIEMENS HEALTHINEERS AG	+3.12%	6.65TCr
EDWARDS LIFESCIENCES CORPORATION	+17.38%	5.39TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-4.51%	4.63TCr
AGILENT TECHNOLOGIES, INC.	-5.77%	3.82TCr
GE HEALTHCARE TECHNOLOGIES INC.	+3.71%	3.66TCr

Other Advanced Medical Equipment & Technology